T-RDN or A-RDN restored diuretic and natriuretic effects of GLP-1 (Fig. 8) and has potential therapeutic implication for use of the new catheter based renal denervation technique in diabetic HF patients [74–76]. This evidence concerns the gene GLP1R and hydrops fetalis.